Positive blood cultures for yeast should not be regarded as a contaminant but should be treated as invasive disease
Empiric antifungal therapy should be considered in ICU patients with risk factors for invasive candidiasis and no other cause of fever (IDSA guidelines)
Species identification and susceptibility tests should be used to guide therapy
Order β-D-glucan antigen test and blood cultures for patients started on empiric antifungal therapy (echinocandin or azole) with high suspicion of invasive candidiasis